Zijian Liu

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer

Zijian Liu, Mi Mi, Xiaoqian Li et al. · Journal of Cellular and Molecular Medicine · 2020 · 118 citations · Full text

Life Sciences, Bioinformatics, Oncology +17

lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network

Zijian Liu, Mi Mi, Xiaoqian Li et al. · Frontiers in Genetics · 2019 · 53 citations · Full text

Medicine, Cancer Biology, Oncology +17

Identification of Hub Genes and Key Pathways Associated with Two Subtypes of Diffuse Large B-Cell Lymphoma Based on Gene Expression Profiling via Integrated Bioinformatics

Zijian Liu, Jingshu Meng, Xiaoqian Li et al. · BioMed Research International · 2018 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +17

Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma

Nian Liu, Zijian Liu, Xinxin Liu et al. · Frontiers in Oncology · 2019 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +17

Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer

Xin Zheng, Zijian Liu, Mi Mi et al. · Frontiers in Oncology · 2021 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17